Literature DB >> 7496337

Posterior drainage of intraocular fluid: an experimental approach on bovine cadaver eyes.

K A Rezai1, B Kirchhof, K Heimann.   

Abstract

We evaluated the posterior drainage of saline in cadaver bovine eyes using different experimental procedures. The saline perfusion via a pars plana infusion into the vitreous cavity was measured in the following 5 different groups of 20 enucleated bovine eyes: 1, control; 2, vitrectomy; 3, vitrectomy + retinectomy; 4, vitrectomy + retinectomy + removal of retinal pigment epithelium (RPE); and 5, vitrectomy + retinectomy + removal of RPE + choroidectomy. The mean values obtained for the facility of saline outflow were as follows group 1, 0.0458 microliter min-1 mmHg-1; group 2, 0.0393 microliter min-1; group 3, 0.1308 microliter min-1 mmHg-1; group 4, 0.2288 microliter min-1; and group 5, 0.9985 microliter/min-1 mmHg-1. The retina appeared to be the major barrier to fluid movement from the vitreous to the chorioid, perhaps due to the lack of extracellular space and to the tight and impervious structure of the retina. The barrier function of the retina may explain the hypotony seen after rhegmatogenous retinal detachment and the decrease in intraocular pressure observed after the removal of silicone oil in eyes that had undergone retinectomy. Our results suggest that the reduction in intraocular pressure occurring after retinectomy is attributable to the new drainage pathway.

Entities:  

Mesh:

Year:  1995        PMID: 7496337

Source DB:  PubMed          Journal:  Ger J Ophthalmol        ISSN: 0941-2921


  2 in total

1.  [Minimally invasive iridocorneal angle surgery].

Authors:  J F Jordan
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

2.  Cyclodialysis ab interno as a surgical approach to intractable glaucoma.

Authors:  Jens F Jordan; Thomas S Dietlein; Sven Dinslage; Christoph Lüke; Walter Konen; Günter K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 3.535

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.